Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 8NETWORK 6NIH 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 3pembrolizumab 2Metformin 2Laparoscopy 2Gemcitabine 2Capecitabine 2tremelimumab 1sintilimab 1nabiximols 1lenvatinib 1enzalutamide 1durvalumab 1capivasertib 1avelumab 1atezolizumab 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Zoledronic Acid 1Trastuzumab 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Rituximab 1Rehabilitation 1Radiotherapy, Conformal 1Radiosurgery 1Radiation Dose Hypofractionation 1Radiation 1Rabeprazole 1Proton Pump Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × OTHER_GOV × Radiotherapy, Conformal × Clear all
NCT05318274 2026-03-23

Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.

Coordinación de Investigación en Salud, Mexico

Phase NA Active not recruiting
72 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡